Strong Pdgfrβ expression ranged from 2 to 60% of p18−/−;Brca1+/− tumor cells, while Pdgfrβ expression was found in 2–5% of p18−/− tumor cells and was much weaker in intensity. The gene discussed is BRCA1; the disease is neoplasm.